会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • USE OF GINSENG EXTRACT, GINSENOSIDE AND GINSENOSIDE DERIVATIVE IN THE PREPARATION OF MEDICINE OR HEALTH CARE PRODUCT FOR TREATING CYTOMEGALOVIRUS INFECTION DISORDERS
    • 人参提取物,人参皂苷和人参皂苷衍生物在制备用于治疗巨细胞病毒感染疾病的医药或保健品中的用途
    • EP3295950A1
    • 2018-03-21
    • EP16795777.8
    • 2016-04-21
    • Fu, Li
    • WANG, KaiqianHUI, MinLI, FanFAN, HongyuWANG, Shuo
    • A61K36/9068A61P31/12
    • The invention discloses new application of a ginseng extract, ginsenoside and a ginsenoside derivative in the preparation of a medicine for treating HCMV infection related diseases. The related diseases comprise HCMV infection caused in the process of treating cardiovascular and cerebrovascular diseases, organ transplantation, perinatal periods, tumors, burn, AIDS and other diseases of patients. Tests prove that the ginseng extract, the ginsenoside and the ginsenoside derivative have a remarkable curative effect, quick response and a small toxic or side effect during treatment of HCMV infected diseases, are a medicine or a health product for treating the HCMV infection, which is safe, efficient and stable and has a simple preparation process, and are suitable for industrial production and easy to popularize. In the invention, a new medicine source is provided for the treatment of the HCMV infection.
    • 本发明公开了人参提取物,人参皂苷和人参皂苷衍生物在制备治疗HCMV感染相关疾病的药物中的新用途。 相关疾病包括在治疗心血管和脑血管疾病,器官移植,围产期,肿瘤,烧伤,艾滋病等患者疾病过程中引起的HCMV感染。 试验证明,人参提取物,人参皂苷和人参皂苷衍生物在治疗HCMV感染的疾病中疗效显着,反应快,毒副作用小,是治疗HCMV感染的药物或保健品, 安全,高效,稳定,制备工艺简单,适合工业化生产,易于普及。 在本发明中,提供了用于治疗HCMV感染的新药物来源。